Skeletal muscle anabolism is a side effect of therapy with the MEK inh
- This topic has 0 replies, 1 voice, and was last updated 12 years, 3 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor: selumetinib in patients with cholangiocarcinoma.
http://www.nature.com/bjc/journal/vaop/ncurrent/full/bjc2012144a.html
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.